Follow The Filings

HTFL Heartflow Inc.

Health Care, filed as HEARTFLOW INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.1%
  • $95M
  • 1 reduce

In 2026 Q2 Ron Baron trimmed Heartflow.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Ron Baron, Bamco Inc. (Baron Capital)). Not free-float ownership.

  1. Ron Baron Reduce 0.14%

Who owns HTFL

Sorted by value, long equity only, as of 2026 Q2.

History
Ron Baron, Bamco Inc. (Baron Capital) 0.14%, was 0.28% Reduce −15.7% 3,225,133 $95M History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by HTFL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All HTFL insider trades
  • $1.1M bought by 1 insider
  • $115M sold by 1 insider outside a trading plan
  • $25M sold by 4 insiders under 10b5-1 plans
  1. John C.m. Farquhar CEO
    Planned sale
    $1.9M 38,900 shares at $49.57 12% of stake
    Traded Oct 12 Filed Oct 14
    ↗
  2. Campbell Rogers Chief Medical Officer
    Planned sale
    $987K 19,682 shares at $50.15 20% of stake
    Traded Sep 18 Filed Sep 21
    ↗
  3. Vikram Verghese CFO
    Planned sale
    $1.2M 24,345 shares at $50.55 14% of stake
    Traded Sep 17–18 Filed Sep 18
    ↗
  4. Vikram Verghese CFO
    Planned sale
    $1.8M 34,975 shares at $50.08 16% of stake
    Traded Sep 11–15 Filed Sep 15
    ↗
  5. John C.m. Farquhar CEO
    Planned sale
    $1.8M 38,900 shares at $46.78 11% of stake
    Traded Sep 10–11 Filed Sep 14
    ↗
  6. Vikram Verghese CFO
    Planned sale
    $332K 6,640 shares at $50.03 3% of stake
    Traded Sep 8 Filed Sep 10
    ↗
  7. Vikram Verghese CFO
    Planned sale
    $1.7M 33,416 shares at $49.85 13% of stake
    Traded Sep 2–3 Filed Sep 4
    ↗
  8. John C.m. Farquhar CEO
    Planned sale
    $1.4M 27,230 shares at $50.00 7% of stake
    Traded Aug 21 Filed Aug 25
    ↗
  9. John C.m. Farquhar CEO
    Planned sale
    $1.5M 32,676 shares at $45.00 7.8% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  10. Campbell Rogers Chief Medical Officer
    Planned sale
    $380K 9,219 shares at $41.23 9.6% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  11. John C.m. Farquhar CEO
    Planned sale
    $608K 15,560 shares at $39.06 3.6% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  12. John C.m. Farquhar CEO
    Planned sale
    $639K 22,562 shares at $28.31 4.9% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  13. Campbell Rogers Chief Medical Officer
    Planned sale
    $237K 9,219 shares at $25.72 9.4% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  14. John C.m. Farquhar CEO
    Planned sale
    $626K 22,562 shares at $27.75 4.9% of stake
    Traded Jul 10 Filed Jul 13
    ↗
  15. John C.m. Farquhar CEO
    Planned sale
    $1.4M 38,900 shares at $35.00 7.8% of stake
    Traded Jun 24 Filed Jun 26
    ↗

Also filed in the last 12 months, not counted as buying or selling: 28 option exercises, 24 share withholdings for taxes, 7 stock grants, and 2 other transactions.

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2025
Revenue $176.03M
Gross profit $135.2M
Gross margin * 76.8%
Net income -$116.79M
Net margin * -66.3%

Balance sheet

Metric FY2025
Total current assets $220.2M
Total non-current assets * $139.25M
Total assets $359.45M
Total current liabilities $42.37M
Total non-current liabilities * $16.44M
Total equity $300.65M

Cash flow

Metric FY2025
Cash from operations -$54.02M
Cash from investing -$238.57M
Cash from financing $286.04M
Net change in cash -$6.36M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.